Report cover image

Global Oral Hair Loss Medication Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 109 Pages
SKU # APRC20340094

Description

Summary

According to APO Research, The global Oral Hair Loss Medication market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Oral Hair Loss Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Oral Hair Loss Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Oral Hair Loss Medication is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Oral Hair Loss Medication include Zhejiang Xianju Pharmaceutical, Shanxi Ante Bio-pharmaceutical, Merck & Co., Pfizer, China Resources Double-crane Pharmaceutical, Teva Pharmaceuticals, Sandoz, Organon Pharma and Marksans Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Hair Loss Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Hair Loss Medication.

The Oral Hair Loss Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Hair Loss Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Oral Hair Loss Medication Segment by Company

Zhejiang Xianju Pharmaceutical
Shanxi Ante Bio-pharmaceutical
Merck & Co.
Pfizer
China Resources Double-crane Pharmaceutical
Teva Pharmaceuticals
Sandoz
Organon Pharma
Marksans Pharma
Aurobindo Pharma
Oral Hair Loss Medication Segment by Type

Finasteride
Minoxidil
Oral Hair Loss Medication Segment by Application

Male Hair Loss
Female Hair Loss
Oral Hair Loss Medication Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Hair Loss Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Hair Loss Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Hair Loss Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Hair Loss Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oral Hair Loss Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

109 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Oral Hair Loss Medication Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Oral Hair Loss Medication Sales Estimates and Forecasts (2020-2031)
1.3 Oral Hair Loss Medication Market by Type
1.3.1 Finasteride
1.3.2 Minoxidil
1.4 Global Oral Hair Loss Medication Market Size by Type
1.4.1 Global Oral Hair Loss Medication Market Size Overview by Type (2020-2031)
1.4.2 Global Oral Hair Loss Medication Historic Market Size Review by Type (2020-2025)
1.4.3 Global Oral Hair Loss Medication Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Oral Hair Loss Medication Sales Breakdown by Type (2020-2025)
1.5.2 Europe Oral Hair Loss Medication Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Oral Hair Loss Medication Sales Breakdown by Type (2020-2025)
1.5.4 South America Oral Hair Loss Medication Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Oral Hair Loss Medication Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Oral Hair Loss Medication Industry Trends
2.2 Oral Hair Loss Medication Industry Drivers
2.3 Oral Hair Loss Medication Industry Opportunities and Challenges
2.4 Oral Hair Loss Medication Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Oral Hair Loss Medication Revenue (2020-2025)
3.2 Global Top Players by Oral Hair Loss Medication Sales (2020-2025)
3.3 Global Top Players by Oral Hair Loss Medication Price (2020-2025)
3.4 Global Oral Hair Loss Medication Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Oral Hair Loss Medication Major Company Production Sites & Headquarters
3.6 Global Oral Hair Loss Medication Company, Product Type & Application
3.7 Global Oral Hair Loss Medication Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oral Hair Loss Medication Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Hair Loss Medication Players Market Share by Revenue in 2024
3.8.3 2023 Oral Hair Loss Medication Tier 1, Tier 2, and Tier 3
4 Oral Hair Loss Medication Regional Status and Outlook
4.1 Global Oral Hair Loss Medication Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Oral Hair Loss Medication Historic Market Size by Region
4.2.1 Global Oral Hair Loss Medication Sales in Volume by Region (2020-2025)
4.2.2 Global Oral Hair Loss Medication Sales in Value by Region (2020-2025)
4.2.3 Global Oral Hair Loss Medication Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Oral Hair Loss Medication Forecasted Market Size by Region
4.3.1 Global Oral Hair Loss Medication Sales in Volume by Region (2026-2031)
4.3.2 Global Oral Hair Loss Medication Sales in Value by Region (2026-2031)
4.3.3 Global Oral Hair Loss Medication Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Oral Hair Loss Medication by Application
5.1 Oral Hair Loss Medication Market by Application
5.1.1 Male Hair Loss
5.1.2 Female Hair Loss
5.2 Global Oral Hair Loss Medication Market Size by Application
5.2.1 Global Oral Hair Loss Medication Market Size Overview by Application (2020-2031)
5.2.2 Global Oral Hair Loss Medication Historic Market Size Review by Application (2020-2025)
5.2.3 Global Oral Hair Loss Medication Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Oral Hair Loss Medication Sales Breakdown by Application (2020-2025)
5.3.2 Europe Oral Hair Loss Medication Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Oral Hair Loss Medication Sales Breakdown by Application (2020-2025)
5.3.4 South America Oral Hair Loss Medication Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Oral Hair Loss Medication Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Zhejiang Xianju Pharmaceutical
6.1.1 Zhejiang Xianju Pharmaceutical Comapny Information
6.1.2 Zhejiang Xianju Pharmaceutical Business Overview
6.1.3 Zhejiang Xianju Pharmaceutical Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zhejiang Xianju Pharmaceutical Oral Hair Loss Medication Product Portfolio
6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
6.2 Shanxi Ante Bio-pharmaceutical
6.2.1 Shanxi Ante Bio-pharmaceutical Comapny Information
6.2.2 Shanxi Ante Bio-pharmaceutical Business Overview
6.2.3 Shanxi Ante Bio-pharmaceutical Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shanxi Ante Bio-pharmaceutical Oral Hair Loss Medication Product Portfolio
6.2.5 Shanxi Ante Bio-pharmaceutical Recent Developments
6.3 Merck & Co.
6.3.1 Merck & Co. Comapny Information
6.3.2 Merck & Co. Business Overview
6.3.3 Merck & Co. Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck & Co. Oral Hair Loss Medication Product Portfolio
6.3.5 Merck & Co. Recent Developments
6.4 Pfizer
6.4.1 Pfizer Comapny Information
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Oral Hair Loss Medication Product Portfolio
6.4.5 Pfizer Recent Developments
6.5 China Resources Double-crane Pharmaceutical
6.5.1 China Resources Double-crane Pharmaceutical Comapny Information
6.5.2 China Resources Double-crane Pharmaceutical Business Overview
6.5.3 China Resources Double-crane Pharmaceutical Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.5.4 China Resources Double-crane Pharmaceutical Oral Hair Loss Medication Product Portfolio
6.5.5 China Resources Double-crane Pharmaceutical Recent Developments
6.6 Teva Pharmaceuticals
6.6.1 Teva Pharmaceuticals Comapny Information
6.6.2 Teva Pharmaceuticals Business Overview
6.6.3 Teva Pharmaceuticals Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceuticals Oral Hair Loss Medication Product Portfolio
6.6.5 Teva Pharmaceuticals Recent Developments
6.7 Sandoz
6.7.1 Sandoz Comapny Information
6.7.2 Sandoz Business Overview
6.7.3 Sandoz Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sandoz Oral Hair Loss Medication Product Portfolio
6.7.5 Sandoz Recent Developments
6.8 Organon Pharma
6.8.1 Organon Pharma Comapny Information
6.8.2 Organon Pharma Business Overview
6.8.3 Organon Pharma Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Organon Pharma Oral Hair Loss Medication Product Portfolio
6.8.5 Organon Pharma Recent Developments
6.9 Marksans Pharma
6.9.1 Marksans Pharma Comapny Information
6.9.2 Marksans Pharma Business Overview
6.9.3 Marksans Pharma Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Marksans Pharma Oral Hair Loss Medication Product Portfolio
6.9.5 Marksans Pharma Recent Developments
6.10 Aurobindo Pharma
6.10.1 Aurobindo Pharma Comapny Information
6.10.2 Aurobindo Pharma Business Overview
6.10.3 Aurobindo Pharma Oral Hair Loss Medication Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Aurobindo Pharma Oral Hair Loss Medication Product Portfolio
6.10.5 Aurobindo Pharma Recent Developments
7 North America by Country
7.1 North America Oral Hair Loss Medication Sales by Country
7.1.1 North America Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Oral Hair Loss Medication Sales by Country (2020-2025)
7.1.3 North America Oral Hair Loss Medication Sales Forecast by Country (2026-2031)
7.2 North America Oral Hair Loss Medication Market Size by Country
7.2.1 North America Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Oral Hair Loss Medication Market Size by Country (2020-2025)
7.2.3 North America Oral Hair Loss Medication Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Oral Hair Loss Medication Sales by Country
8.1.1 Europe Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Oral Hair Loss Medication Sales by Country (2020-2025)
8.1.3 Europe Oral Hair Loss Medication Sales Forecast by Country (2026-2031)
8.2 Europe Oral Hair Loss Medication Market Size by Country
8.2.1 Europe Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Oral Hair Loss Medication Market Size by Country (2020-2025)
8.2.3 Europe Oral Hair Loss Medication Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Oral Hair Loss Medication Sales by Country
9.1.1 Asia-Pacific Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Oral Hair Loss Medication Sales by Country (2020-2025)
9.1.3 Asia-Pacific Oral Hair Loss Medication Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Oral Hair Loss Medication Market Size by Country
9.2.1 Asia-Pacific Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Oral Hair Loss Medication Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Oral Hair Loss Medication Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Oral Hair Loss Medication Sales by Country
10.1.1 South America Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Oral Hair Loss Medication Sales by Country (2020-2025)
10.1.3 South America Oral Hair Loss Medication Sales Forecast by Country (2026-2031)
10.2 South America Oral Hair Loss Medication Market Size by Country
10.2.1 South America Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Oral Hair Loss Medication Market Size by Country (2020-2025)
10.2.3 South America Oral Hair Loss Medication Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Oral Hair Loss Medication Sales by Country
11.1.1 Middle East and Africa Oral Hair Loss Medication Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Oral Hair Loss Medication Sales by Country (2020-2025)
11.1.3 Middle East and Africa Oral Hair Loss Medication Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Oral Hair Loss Medication Market Size by Country
11.2.1 Middle East and Africa Oral Hair Loss Medication Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Oral Hair Loss Medication Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Oral Hair Loss Medication Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Oral Hair Loss Medication Value Chain Analysis
12.1.1 Oral Hair Loss Medication Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Oral Hair Loss Medication Production Mode & Process
12.2 Oral Hair Loss Medication Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Oral Hair Loss Medication Distributors
12.2.3 Oral Hair Loss Medication Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us